Last reviewed · How we verify
Sequence A T-R-T-R
At a glance
| Generic name | Sequence A T-R-T-R |
|---|---|
| Sponsor | Shenzhen Salubris Pharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (PHASE1)
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood (PHASE1)
- Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer (PHASE1)
- Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. (PHASE1)
- Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets (NA)
- Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans (PHASE1)
- A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood (PHASE1)
- Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |